UK markets close in 6 hours 18 minutes

Mydecine Innovations Group Inc. (MYCOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0062-0.0048 (-43.75%)
At close: 02:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
7.493
0
7.493
2.617
125.572
Cost of revenue
-
0
0
0
94.048
Gross profit
-
0
7.493
2.617
31.524
Operating expenses
Research development
4,247
3,589
3,960
1,291
0
Selling general and administrative
15,692
9,821
13,819
7,360
3,204
Total operating expenses
20,168
16,389
22,692
11,462
3,426
Operating income or loss
-20,160
-16,389
-22,684
-11,459
-3,394
Interest expense
742.445
911.594
205.267
182.866
80.517
Total other income/expenses net
-1,766
59.158
-693.508
-15,234
-17,955
Income before tax
-22,669
-17,242
-23,583
-26,876
-21,429
Income from continuing operations
-22,669
-17,242
-23,583
-26,876
-21,429
Net income
-22,353
-11,567
-28,897
-26,949
-21,429
Net income available to common shareholders
-22,353
-11,567
-28,897
-26,949
-21,429
Basic EPS
-1.20
-1.34
-6.17
-12.05
-48.00
Diluted EPS
-1.20
-1.34
-6.17
-12.05
-48.00
Basic average shares
45,207
8,647
4,682
2,274
445.465
Diluted average shares
45,207
8,647
4,682
2,274
445.465